The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: Potential implication in hypertension

Clinical Science

Volumn 116, Issue 3, 2009, Pages 233-240

  San José, Gorka ^a   Fortuño, Ana ^a   Moreno, María U ^a   Robador, Pablo A ^a   Bidegain, Julen ^a   Varo, Nerea ^a   Beloqui, Oscar ^b   Díez, Javier ^a,b   Zalba, Guillermo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Angiotensin converting enzyme (ACE); Essential hypertension; I D polymorphism; Matrix metalloproteinase 9 (MMP 9); NADPH oxidase; Superoxide

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; LIPID;

ADULT; AGE; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENDER; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHAGOCYTE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

CASE-CONTROL STUDIES; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; LIPIDS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; NADPH OXIDASE; PEPTIDYL-DIPEPTIDASE A; PHAGOCYTES; POLYMORPHISM, GENETIC; SUPEROXIDES;

EID: 60549106862     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080057     Document Type: Article

References (40)

1. Sayed-Tabatabaei, F. A., Oostra, B. A., Isaacs, A., van Duijn, C. M. and Witteman, J. C. (2006) ACE polymorphisms. Circ. Res. 98, 1123-1133
2. Dell'omo, G., Penno, G. and Pucci, L. et al. (2006) ACE gene insertion/ deletion polymorphism modulates capillary permeability in hypertension. Clin. Sci. 111, 357-364
3. Takahashi, T., Ueno, H. and Yasumoto, K. et al. (2003) Angiotensin-converting enzyme-gene polymorphism is associated with collagen I synthesis and QT dispersion in essential hypertension. J. Hypertens. 21, 985-991
4. Perticone, F., Maio, R., Di Paola, R. et al. (2007) Role of PC-1 and ACE genes on insulin resistance and cardiac mass in never-treated hypertensive patients. Suggestive evidence for a digenic additive modulation. Nutr. Metab. Cardiovasc. Dis. 17, 181-187
5. Redón, J., Chaves, F. J., Liao, Y. et al. (2000) Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension. Hypertension 35, 490-495
6. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P. and Soubrier, F. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86, 1343-1346
7. Costerousse, O., Allegrini, J., Lopez, M. and Alhenc-Gelas, F. (1993) Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem. J. 290, 33-40
8. Danser, A. H., Schalekamp, M. A., Bax, W. A. et al. (1995) Angiotensin-converting enzyme in the human heart. Effect of the deletion/ insertion polymorphism. Circulation 92, 1387-1388
9. Mizuiri, S., Hemmi, H., Kumanomidou, H. et al. (2001) Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression. Kidney Int. 60, 1124-1130
10. Ueda, S., Elliott, H. L., Morton, J. J. and Connell, J. M. (1995) Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 25, 1266-1269
11. Landmesser, U. and Harrison, D. G. (2001) Oxidative stress and vascular damage in hypertension. Coron. Artery Dis. 12, 455-461
12. Alexander, R. W. (1995) Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25, 155-161
13. Taniyama, Y. and Griendling, K. K. (2003) Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42, 1075-1081
14. Touyz, R. M. and Schiffrin, E. L. (2001) Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J. Hypertens. 19, 1245-1254
15. Fortuño, A., Oliván, S. and Beloqui, O. et al. (2004) Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J. Hypertens. 22, 2169-2175
16. Pettit, A. I., Wong, R. K., Lee, V., Jennings, S., Quinn, P. A. and Ng, L. L. (2002) Increased free radical production in hypertension due to increased expression of the NADPH oxidase subunit p22(phox) in lymphoblast cell lines. J. Hypertens. 20, 677-683
17. Guzik, T. J., West, N. E., Black, E. et al. (2000) Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ. Res. 86, E85-E90
18. Azumi, H., Inoue, N., Takeshita, S. et al. (1999) Expression of NADH/ NADPH oxidase p22phox in human coronary arteries. Circulation 100, 1494-1498
19. Kalinina, N., Agrotis, A., Tararak, E. et al. (2002) Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 22, 2037-2043
20. Sorescu, D., Weiss, D., Lassegue, B. et al. (2002) Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105, 1429-1435
21. Azumi, H., Inoue, N., Ohashi, Y. et al. (2002) Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler. Thromb. Vasc. Biol. 22, 1838-1844
22. Zalba, G., Beloqui, O., San José, G., Moreno, M. U., Fortuño, A. and Díez, J. (2005) NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease. Arterioscler. Thromb. Vasc. Biol. 25, 1452-1457
23. Zalba, G., Fortuño, A., Orbe, J. et al. (2007) Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 587-593
24. Germano, G., Sanguigni, V., Pignatelli, P. et al. (2004) Enhanced platelet release of superoxide anion in systemic hypertension: role of AT1 receptors. J. Hypertens. 22, 1151-1156
25. Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D. and Alexander, R. W. (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74, 1141-1148
26. Zhang, H., Schmeisser, A., Garlichs, C. D. et al. (1999) Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc. Res. 44, 215-222
27. Pagano, P. J., Chanock, S. J., Siwik, D. A., Colucci, W. S. and Clark, J. K. (1998) Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension 32, 331-337
28. Rigat, B., Hubert, C., Corvol, P. and Soubrier, F. (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 20, 1433
29. Shanmugam, V., Sell, K. W. and Saha, B. K. (1993) Mistyping ACE heterozygotes. PCR Methods Appl. 3, 120-121
30. Rajagopalan, S., Kurz, S., Munzel, T. et al. (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97, 1916-1923
31. Touyz, R. M. (2005) Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp. Physiol. 90, 449-455
32. Zalba, G., San José, G., Moreno, M. U. et al. (2001) Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 38, 1395-1399
33. Zalba, G., San José, G., Moreno, M. U., Fortuño, A. and Díez, J. (2005) NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension. Antioxid. Redox Signaling 7, 1327-1336
34. Pedro-Botet, J., Covas, M. I., Martín, S. and Rubies-Prat, J. (2000) Decreased endogenous antioxidant enzymatic status in essential hypertension. J. Hum. Hypertens. 14, 343-345
35. Sayed-Tabatabaei, F. A., Houwing-Duistermaat, J. J., van Duijn, C. M. and Witteman, J. C. (2003) Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis. Stroke 34, 1634-1639
36. Ridker, P. M., Brown, N. J., Vaughan, D. E., Harrison, D. G. and Mehta, J. L. (2004) Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109, IV6-IV19
37. Li, Y., Zagato, L., Kuznetsova, T. et al. (2007) Angiotensin-converting enzyme I/D and α-adducin Gly460Trp polymorphisms: from angiotensin-converting enzyme activity to cardiovascular outcome. Hypertension 49, 1291-1297
38. Murphey, L. J., Gainer, J. V., Vaughan, D. E. and Brown, N. J. (2000) Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 102, 829-832
39. Arnett, D. K., Claas, S. A. and Glasser, S. P. (2006) Pharmacogenetics of antihypertensive treatment. Vasc. Pharmacol. 44, 107-118
40. Muthumala, A., Montgomery, H., Palmen, J., Cooper, J. A. and Humphries, S. E. (2007) Angiotensin-converting enzyme genotype interacts with systolic blood pressure to determine coronary heart disease risk in healthy middle-aged men. Hypertension 50, 348-353